Skip to main content
Martin Maron, MD, Cardiology, Burlington, MA

Martin S Maron MD

Adult Congenital Heart Disease


Assistant Professor of Medicine

Join to View Full Profile
  • 41 Mall RdBurlington, MA 01805

  • Phone+1 781-744-8000

  • Fax+1 617-636-6204

Dr. Maron is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Martin Maron, MD, serves as the Director of the Hypertrophic Cardiomyopathy Center and the Co-Director of the Cardiac CT and MRI program at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imagining, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. He was the Hypertrophic Cardiomyopathy Association’s 2011 Clinician of the Year, and currently serves on the association’s Board of Directors. He is board certified in Cardiovascular Disease and Internal Medicine.

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Cardiovascular Disease, 2002 - 2005
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2001
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2027
  • NH State Medical License
    NH State Medical License 2024 - 2026
  • NJ State Medical License
    NJ State Medical License 2013 - 2023
  • FL State Medical License
    FL State Medical License 2019 - 2021
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mini-Focus Issue: Hypertrophic Cardiomyopathy State-of-the-Art Review Clinical Spectrum and Management of Heart Failure in Hypertrophic Cardiomyopathy  
    Martin S Maron, Barry J Maron, James E Udelson, Ethan J Rowin, ScienceDirect

Lectures

  • HCM and its Many Variations: When to Suspect and How to Diagnose? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Other

Press Mentions

  • In Memoriam: Eugene Braunwald, MD, MACC
    In Memoriam: Eugene Braunwald, MD, MACCApril 23rd, 2026
  • FDA Approves New Drug for Genetic Heart Disease
    FDA Approves New Drug for Genetic Heart DiseaseDecember 19th, 2025
  • Aficamten Effective, Safe in Patients with Mild Obstructive HCM Symptoms
    Aficamten Effective, Safe in Patients with Mild Obstructive HCM SymptomsMay 29th, 2025

Grant Support

  • Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMRBETH ISRAEL DEACONESS MEDICAL CENTER2025–2030
  • Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCMBETH ISRAEL DEACONESS MEDICAL CENTER2021–2025
  • Clinical And Therapeutic Implications Of Fibrosis In Hypertrophic CardiomyopathyNational Heart, Lung, And Blood Institute2007–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: